{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:02:56Z","timestamp":1789437776368,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-026-14921-4","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:58:00Z","timestamp":1782712680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perceptions, challenges, and improvement strategies for reducing intravenous infusion use in hospitalised patients within Chinese medical institutions: a qualitative interview study"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiaoyan","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"issue":"10","key":"14921_CR1","first-page":"4","volume":"28","author":"P LUO","year":"2021","unstructured":"Luo P, Yin T, Liu S, et al. Quality and safety management of Chinese hospitals: Development and implementation evaluation of the Infusion Safety group standard. Chin Health Qual Manage. 2021;28(10):4.","journal-title":"Chin Health Qual Manage"},{"key":"14921_CR2","unstructured":"National Center for ADR Monitoring, China. (2024, March 26). National Adverse Drug Reaction Monitoring Annual Report (2023). Retrieved June 23, 2024, from https:\/\/www.cdr-adr.org.cn\/drug_1\/aqjs_1\/drug_aqjs_sjbg\/202403\/t20240326_50614.html."},{"issue":"4","key":"14921_CR3","first-page":"30","volume":"30","author":"W Zuo","year":"2023","unstructured":"Zuo W, Zhou L, Gao DH, Chen X, Zhang YX, Mei D, Yan Q. Investigation on status of intravenous infusion among inpatients in secondary and above general hospitals in China. Chin Health Qual Manage. 2023;30(4):30\u20133.","journal-title":"Chin Health Qual Manage"},{"issue":"5","key":"14921_CR4","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s11096-019-00898-0","volume":"41","author":"S Zeng","year":"2019","unstructured":"Zeng S, Wang D, Liu W, et al. Overuse of intravenous infusions in China: focusing on management platform and cultural problems. Int J Clin Pharm. 2019;41(5):1133\u20137.","journal-title":"Int J Clin Pharm"},{"key":"14921_CR5","unstructured":"National Health Commission of the People\u2019s Republic of China. Notice on the Issuance of the National Medical Quality and Safety Improvement Goals for 2021. National Health Commission Office Document No. [2021] 76. 2021 Feb 9."},{"key":"14921_CR6","unstructured":"National Health Commission of the People\u2019s Republic of China. Notice on the Issuance of the National Medical Quality and Safety Improvement Goals for 2022. National Health Commission Office Document No. [2022] 58. 2022 Mar 2."},{"key":"14921_CR7","unstructured":"National Health Commission of the People\u2019s Republic of China. Notice on the Issuance of the National Medical Quality and Safety Improvement Goals for 2023. National Health Commission Office Document No. [2023] 45. 2023 Mar 28."},{"key":"14921_CR8","unstructured":"National Health Commission of the People\u2019s Republic of China. Notice of the General Office of the National Health Commission on issuing the National Medical Quality and Safety Improvement Goals for 2024. National Health Commission Office Document No. [2024] 40. 2024 Feb 1. In Chinese."},{"key":"14921_CR9","unstructured":"National Institute of Hospital Administration, National Health Commission; National Center for Pharmaceutical Care Quality Control. Notice on issuing the Pilot Work Plan for Clinical Use Management of Intravenous Infusion in Inpatients. Beijing: National Institute of Hospital Administration, National Health Commission. 2023 Sep 4. Appendix 1, Monitoring indicators for intravenous infusion use in inpatients; p. 8. In Chinese."},{"key":"14921_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-4-50","volume":"4","author":"LJ Damschroder","year":"2009","unstructured":"Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.","journal-title":"Implement Sci"},{"key":"14921_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1748-5908-6-42","volume":"6","author":"S Michie","year":"2011","unstructured":"Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42.","journal-title":"Implement Sci"},{"issue":"6","key":"14921_CR12","first-page":"3","volume":"21","author":"CHEN Er-yang","year":"2018","unstructured":"Chen Er-yang. Yu-ye. Investigation and Analysis of Primary Hospital Medical Staff\u2019s Cognition of Clinical Pharmacy Work. Chin Pharmacist. 2018;21(6):3.","journal-title":"Chin Pharmacist"},{"key":"14921_CR13","first-page":"036","volume":"002","author":"ZHANG Nan","year":"2022","unstructured":"Zhang N, Xia W, Yang H, et al. Discussion on the clinical pharmacist\u2019s participation in the rational drug use management model under the DRG payment system. Chin Pharm. 2022;002:036.","journal-title":"Chin Pharm"},{"issue":"2","key":"14921_CR14","first-page":"6","volume":"33","author":"GE Xin","year":"2024","unstructured":"Xin GE, Ping LIU, Shiwei ZHANG, et al. The impact of pharmaceutical management intervention based on DRG payment on the rational use of intravenous infusions in primary hospitals. China Pharm. 2024;33(2):6\u201310.","journal-title":"China Pharm"},{"key":"14921_CR15","unstructured":"Wang Y, Zhu Y, He Y. Clinical pharmacists\u2019 participation in rational drug use management using information-based clinical pathways under DRGs: A case study of glycyrrhizic acid preparations for intravenous use. Chin J Mod Appl Pharm. 2024:1\u20136."},{"key":"14921_CR16","doi-asserted-by":"crossref","unstructured":"Sauer BL, Koda-Kimble MA. A changing health care environment. : its impact on UCSF graduates\u2019 practice patterns and perceptions. Am J Pharm Educ. 1998;62(3):252.","DOI":"10.1016\/S0002-9459(24)01995-8"},{"key":"14921_CR17","unstructured":"Qing F, Ce Z. Development and Prospect of Clinical Pharmacists in China.China Pharmacy. 2008;01:65\u20137."},{"issue":"3","key":"14921_CR18","first-page":"3","volume":"41","author":"ZUO Genyong","year":"2022","unstructured":"Zuo G, Bai Z. Behavioral economics research on the linkage of medical services, pharmaceutical services, and medical insurance in medical institutions. Chin Health Econ. 2022;41(3):3.","journal-title":"Chin Health Econ"},{"key":"14921_CR19","unstructured":"Medical Administration Bureau of the National Health Commission of the People\u2019s Republic of China. Notice on Printing and Distributing the Opinions on Strengthening Drug Affairs Management in Medical Institutions to Promote Rational Drug Use [EB\/OL]. (2020-02-26) [Accessed on 2024-06-21]."},{"key":"14921_CR20","unstructured":"National Health Commission of the People\u2019s Republic of China, National Administration of Traditional Chinese Medicine. Opinions on Accelerating the High-Quality Development of Pharmaceutical Services. National Health Commission Document No. [2018] 45, 2018-11-21. Source: National Health Commission Website."},{"key":"14921_CR21","unstructured":"General Office of the State Council of the People\u2019s Republic of China. Notice on Printing and Distributing the Legislative Work Plan of the State Council for the Year 2023 [EB\/OL]. (2023-06-06) [Accessed on 2024-06-21]. State Council Document No. [2023] 18. Source: State Council Policy Document Library."},{"issue":"6","key":"14921_CR22","first-page":"S","volume":"160","author":"ME Sutton,Don","year":"2021","unstructured":"Sutton,Don ME, Rockey C, Su246 OVERUSE OF INTRAVENOUS PROTON-PUMP INHIBITORS IN THE TREATMENT OF LOW TO MODERATE RISK PEPTIC ULCER BLEEDING. Gastroenterology. 2021;160(6):S\u2013653.","journal-title":"Gastroenterology"},{"issue":"5","key":"14921_CR23","first-page":"S","volume":"142","author":"R Curtis","year":"2012","unstructured":"Curtis R, Weaver,Danielle Marino,Arthur J, DeCross, et al. Sa1158 Overuse of Proton Pump Inhibitors in a University Medical Intensive Care Unit. Gastroenterology. 2012;142(5):S\u2013231.","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"14921_CR24","first-page":"A37","volume":"63","author":"D Charlie Owen","year":"2014","unstructured":"Charlie Owen D, Marks P, Panesar. PTU-001 Overuse Of Proton Pump Inhibitors And Strategies To Reduce Inappropriate Prescribing. Gut. 2014;63(Suppl 1):A37.","journal-title":"Gut"},{"key":"14921_CR25","unstructured":"Office of the National Health Commission of the People\u2019s Republic of China. Notice on the Issuance of the Clinical Application Guidelines for Proton Pump Inhibitors (2020 Edition). National Health Commission Office Document No. [2020] 973. 2020 Dec 3. Source: Medical Administration Bureau Website."},{"issue":"15","key":"14921_CR26","first-page":"2","volume":"14","author":"ZHOU Sixing","year":"2020","unstructured":"Zhou S, Liu T, Li J, et al. Impact of quality management circle activities involving clinical physicians on the irrational phenomenon of proton pump inhibitor use. Mod Chin Med. 2020;14(15):2.","journal-title":"Mod Chin Med"},{"issue":"16","key":"14921_CR27","first-page":"4","volume":"40","author":"NAN He","year":"2021","unstructured":"Nan H, Chen H. Current status of knowledge about intravenous infusion therapy among hospitalized patients. Int J Nurs Sci. 2021;40(16):4.","journal-title":"Int J Nurs Sci"},{"issue":"10","key":"14921_CR28","first-page":"1257","volume":"34","author":"SUN Jialin","year":"2023","unstructured":"Sun J, Li X, Ni B, et al. Exploration of the Six-Step Method management model to reduce the use of intravenous infusions in hospitalized patients. Chin Pharm.2023;34(10):1257\u201361.","journal-title":"Chin Pharm"},{"issue":"2","key":"14921_CR29","first-page":"134","volume":"15","author":"ZHANG Liangliang","year":"2024","unstructured":"Zhang L, Xin Z, Yuan S, et al. Practice of multi-departmental collaboration to promote standardized use of intravenous infusions in hospitalized patients. Chin Health Standard Manage. 2024;15(2):134\u20138.","journal-title":"Chin Health Standard Manage"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-14921-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14921-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14921-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:51:14Z","timestamp":1789437074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-026-14921-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14921"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-14921-4","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"31 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the institutional review board of The Affiliated Hospital of Southwest Medical University (protocol number KY2024279). All participants provided written informed consent. Study data were coded (i.e., all identifying information was removed) to protect participant privacy. The study was conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1268"}}